ARCHITECT Syphilis TP - Treponema pallidum immunoglobulin G (IgG)/IgM antibody IVD, kit, chemiluminescent immunoassay

Pays: Australie

Langue: anglais

Source: Department of Health (Therapeutic Goods Administration)

Disponible depuis:

Abbott Australasia Pty Ltd Diagnostic Division

classe:

Class 4

Fabriqué par:

Abbott GmbH Max Planck Ring 2, WIESBADEN, 65205 Germany

Domaine thérapeutique:

59861 - Treponema pallidum immunoglobulin G (IgG)/IgM antibody IVD, kit, chemiluminescent immunoassay

indications thérapeutiques:

A chemiluminescent microparticle immunoassay for the detection of antibodies to treponema pallidum (syphilis) The ARCHITECT Syphilis TP assay is a chemiluminescent microparticle immunoassay (CMIA) for the qualitative detection of antibodies to Treponema pallidum (TP) in human serum and plasma, including specimens collected post-mortem (non-heart-beating) on the ARCHITECT analyser. Performance has been established for the use of cadaveric blood specimens (specimens collected post-mortem, non-heart beating) that have been collected up to 24 hours after death.

Statut de autorisation:

A

Date de l'autorisation:

2014-04-15